Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAIC(Hepatic Artery Infusion Chemotherapy)”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Large-scale testing (Phase 3)UnknownNCT01214343
What this trial is testing

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

Who this might be right for
Advanced Hepatocellular CarcinomaCarcinomaCarcinoma, Hepatocellular+2 more
Ministry of Health, Labour and Welfare, Japan 190
Testing effectiveness (Phase 2)Study completedNCT02981498
What this trial is testing

Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 35
Testing effectiveness (Phase 2)UnknownNCT04947826
What this trial is testing

Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma With Major Portal Vein Thrombosis
Shanghai Zhongshan Hospital 100
Early research (Phase 1)UnknownNCT05533892
What this trial is testing

Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Wan-Guang Zhang 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06389500
What this trial is testing

HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Harbin Medical University 30
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Testing effectiveness (Phase 2)UnknownNCT05886465
What this trial is testing

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 40
Not applicableLooking for participantsNCT06632093
What this trial is testing

HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatic Arterial Infusion Chemotherapy+3 more
First Hospital of China Medical University 84
Testing effectiveness (Phase 2)UnknownNCT05877001
What this trial is testing

The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Peking University Cancer Hospital & Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT06406634
What this trial is testing

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hunan Cancer Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05311319
What this trial is testing

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

Who this might be right for
Hepatocarcinoma
Fudan University 70
Testing effectiveness (Phase 2)Study completedNCT03048123
What this trial is testing

HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 79
Not applicableStudy completedNCT07272265
What this trial is testing

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Large-scale testing (Phase 3)Looking for participantsNCT06492395
What this trial is testing

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 178
Testing effectiveness (Phase 2)UnknownNCT06001567
What this trial is testing

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Who this might be right for
ThrombocytopeniaHepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 30
Large-scale testing (Phase 3)UnknownNCT02767375
What this trial is testing

Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection

Who this might be right for
Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute 192
Testing effectiveness (Phase 2)Looking for participantsNCT06904183
What this trial is testing

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 320
Early research (Phase 1)Study completedNCT06184841
What this trial is testing

HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma

Who this might be right for
Hepatic Arterial Infusion ChemotherapyLiver MetastasesEsophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06482008
What this trial is testing

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 33
Load More Results